Related Experiment Video
Updated: Jan 7, 2026

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
Published on: July 3, 2014
Late-onset intracerebral hemorrhage associated with COL4A1 variants: clinical and genetic perspectives
Xinting Zhuang1,2, Shuyan Xu1,2, Chaohan Chen1,2
1Department of Neurology and Institute of Neurology, Institute of Neuroscience, and Fujian Key Laboratory of Molecular Neurology, the First Affiliated Hospital, Fujian Medical University, 20 Chazhong Road, Fuzhou, 350005, Fujian, China.
Background:
Pathogenic variants in the COL4A1 gene, which encodes a key structural component of the vascular basement membrane, compromise vascular integrity and contribute to a broad spectrum of cerebrovascular disorders. COL4A1-related intracerebral hemorrhage (ICH) demonstrates a distinct bimodal age distribution, characterized by early-onset (perinatal/childhood) and late-onset (adulthood) presentations.Although early-onset phenotypes have been extensively characterized, late-onset intracerebral hemorrhage linked to COL4A1 mutations remains underrecognized, frequently obscured by coexisting vascular risk factors.
Method:
We reported two probands with late-onset intracerebral hemorrhage associated with COL4A1. Structural modeling was performed to assess the potential impact of these variants on collagen stability. Additionally, we reviewed 27 previously published cases to evaluate the association between COL4A1 mutations and ICH.
Results:
We identified two probands with heterozygous COL4A1 missense variants: c.2086G > A (p.Gly696Ser) and a novel c.3110C > T (p.Pro1037Leu). Notably, the patient with the Pro1037Leu variant remained asymptomatic until experiencing a hemorrhagic event.Structural modeling suggests that these variants may induce subtle conformational changes that impair collagen stability. A review of 27 published cases further supports the notion that such intrinsic structural abnormalities, in combination with vascular risk factors (e.g., arterial hypertension), may increase susceptibility to intracerebral hemorrhage.
Conclusion:
The results underscore the importance of considering genetic testing in patients with unexplained or recurrent intracerebral hemorrhage, particularly those with a positive family history or syndromic features. While disease-specific therapies are currently lacking, early molecular diagnosis and rigorous control of modifiable risk factors may improve long-term outcomes and support informed genetic counseling.
More Related Videos
09:14Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins